Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000231627 | SCV000286202 | benign | Dilated cardiomyopathy 1DD | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000520466 | SCV000617940 | uncertain significance | not provided | 2023-06-12 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV002321863 | SCV002610870 | uncertain significance | Cardiovascular phenotype | 2022-10-05 | criteria provided, single submitter | clinical testing | The p.I1090F variant (also known as c.3268A>T), located in coding exon 11 of the RBM20 gene, results from an A to T substitution at nucleotide position 3268. The isoleucine at codon 1090 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000231627 | SCV002786920 | uncertain significance | Dilated cardiomyopathy 1DD | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000231627 | SCV003813788 | uncertain significance | Dilated cardiomyopathy 1DD | 2021-06-11 | criteria provided, single submitter | clinical testing |